A61K 47/6871
The antibody targeting an enzyme
Official title: {the antibody targeting an enzyme}
A61K47/6871 (The antibody targeting an enzyme) appears on 236 US grants and 435 published applications in this corpus.
Search patents in A61K- Granted patents
- 236
- Published applications
- 435
- Assignees
- 208
- Inventors
- 941
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 6 |
| 2002 | 1 | 5 |
| 2003 | 1 | 3 |
| 2004 | 1 | 3 |
| 2005 | 1 | 5 |
| 2006 | 2 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 4 |
| 2009 | 4 | 6 |
| 2010 | 4 | 9 |
| 2011 | 2 | 9 |
| 2012 | 3 | 9 |
| 2013 | 4 | 13 |
| 2014 | 5 | 16 |
| 2015 | 13 | 15 |
| 2016 | 14 | 52 |
| 2017 | 26 | 43 |
| 2018 | 16 | 40 |
| 2019 | 27 | 29 |
| 2020 | 27 | 33 |
| 2021 | 17 | 28 |
| 2022 | 16 | 14 |
| 2023 | 16 | 21 |
| 2024 | 13 | 23 |
| 2025 | 8 | 26 |
| 2026 | 7 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CD38 antibody drug conjugate15 Sep 2026US 12,734,209 B2Ogory, Inc.
- Methods of making targeted vesicles, and compositions made thereby18 Aug 2026US 12,708,670 B2University of Georgia Research Foundation, Inc.
- Binding molecules specific for CD73 and uses thereof19 May 2026US 12,630,648 B2Medlmmune, LLC
- Targeted amatoxin conjugate for the treatment of solid tumors10 Feb 2026US 12,544,419 B2Heidelberg Pharma Research GmbH
- Anti-influenza B virus neuraminidase antibodies and uses thereof10 Feb 2026US 12,545,718 B2Icahn School of Medicine at Mount Sinai
- Fap-targeted antibody-drug conjugates8 Oct 2026US 2026/0306653 A1Oncomatryx Biopharma, S.L.
- Trogocytosis in cancer cells and methods for treating cancer related thereto17 Sep 2026US 2026/0274990 A1Arizona Board of Regents on Behalf of the University of Arizona
- Rabbit monoclonal antibodies targeting acute myeloid leukemia antigens10 Sep 2026US 2026/0265410 A1
- Antibody-conjugates for targeting of tumours expressing ptk727 Aug 2026US 2026/0248939 A1Synaffix B.V.
- Binding molecules specific for cd73 and uses thereof27 Aug 2026US 2026/0250424 A1MedImmune, LLC
Most cited
By later US patents
- Methods of treatment using anti-ErbB antibody-maytansinoid conjugates152US 7,097,840 B2Genentech, Inc. · 2006
- Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression105US 6,767,704 B2Thomas Jefferson University · 2004
- Mutant interleukin-2 polypeptides99US 9,266,938 B2Roche Glycart AG · 2016
- Compositions and methods for identifying and targeting cancer cells of alimentary canal origin84US 7,479,376 B2Thomas Jefferson University · 2009
- Targeted pyrrolobenzodiazapine conjugates74US 9,242,013 B2MedImmune, LLC · 2016